Eloxx Pharmaceuticals' Seed VC Round

Eloxx Pharmaceuticals raised a round of funding on November 22, 2013.

Eloxx Pharmaceuticals (NASDAQ:ELOX) is a clinical stage company developing therapeutics for genetic diseases caused by non-sense mutations.…

Articles about Eloxx Pharmaceuticals' Seed VC Round: